Leo Lee

Mr. Lee has been a member of our board since May 2018. Mr. Lee brings more than 20 years of experience in pharmaceutical innovation, commercialization, regulatory affairs, and policy, and has worked extensively in North America and Asia. Most recently, Mr. Lee served as President, Japan, for Merck KGaA. Prior to his role, he served as President, Japan, for Allergan plc, a global pharmaceutical company, from 2011 to 2015, and as Vice President of Sales at Merck & Co. from 2008 to 2011. From 2003 to 2008, Mr. Lee held various commercial positions at IQVIA (Cegedim Dendrite), a life sciences services company. Mr. Lee also served in various roles at Accelrys, Inc., a software company serving pharmaceutical and biotech companies, from 1997 to 2003. Mr. Lee serves on the board of directors of Regeneus Ltd, a global pharmaceutical company based in Australia. Mr. Lee received a Bachelor of Science in Molecular Genetics and Microbiology from the University of California, Los Angeles. Mr. Lee is a member of the Compensation Committee and the Science & Technology Committee.